Small interfering RNA-mediated silencing of cytochromeP450 3A4 gene


Autoria(s): Chen, Jie; Yang, Xiao-Xia; Huang, Min; Hu, Ze-Ping; He, Ming; Duan, Wei; Chan, Eli; Sheu, Fwu-Shan; Chen, Xiao; Zhou, Shu-Feng
Data(s)

07/06/2006

Resumo

RNA interference (RNAi) is a specific and powerful tool used to manipulate gene expression and study gene function. The cytochrome P450 3A4 (CYP3A4) can metabolize more than 50% of drugs. In the present study, we investigated whether vector-expressed small interfering RNAs (siRNAs) altered the <i>CYP3A4</i> expression and function using the Chinese hamster cell line (V79) overexpressing CYP3A4 (CHL-3A4). Three different siRNA oligonucleotides (3A4I, 3A4II, and 3A4III) were designed and tested for their ability to interfere with <i>CYP3A4</i> gene expression. Our study demonstrated that transient transfection of CHL-3A4 cells with the 3A4III siRNAs, but not 3A4I and II, significantly reduced <i>CYP3A4</i> mRNA levels by 65% and protein expression levels by 75%. All these siRNAs did not affect the expression of <i>CYP3A5</i> at both mRNA and protein levels in V79 cells overexpressing CYP3A5. Transfection of CHL-3A4 cells with 3A4III siRNAs significantly diminished the cytotoxicity of two CYP3A4 substrate drugs, cyclophosphamide and ifosfamide, in CHL-3A4 cells, with the IC<sub>50</sub> increased from 55 to 210 µM to >1000 µM. Nifedipine at 5.78, 14.44, and 28.88 µM was significantly (<i>P</i> < 0.01) depleted by approximately 100, 40, and 22%, respectively, in S9 fractions from CHL-3A4 cells compared with parental CHL-pIC19h cells. In addition, transfection of the CHL-3A4 cells with vectors expressing the 3A4III siRNAs almost completely inhibited CYP3A4-mediated nifedipine metabolism. This study demonstrated, for the first time, the specific suppression of <i>CYP3A4</i> expression and function using vector-based RNAi technique. The use of RNAi is a promising tool for the study of cytochrome P450 family function.<br />

Identificador

http://hdl.handle.net/10536/DRO/DU:30009156

Idioma(s)

eng

Publicador

American Society for Pharmacology and Expreimental Therapeutics

Relação

http://dro.deakin.edu.au/eserv/DU:30009156/n20062215.pdf

http://dx.doi.org/10.1124/dmd.106.009837

Direitos

2006, The American Society for Pharmacology and Experimental Therapeutics

Tipo

Journal Article